Stage specific follow-up strategy after cystectomy for carcinoma of the bladder. - Int J Urol 2002;9:129-133.

By Kuroda M.   Meguro N.   Maeda O.   Saiki S.   Kinouchi T.   Usami M.   Kotake T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 170-170

Elsevier

Access to resources Recommend Favorite

The use of the marker tumor concept in Ta, T1 bladder cancer - Is it justified?

By van der Meijden A.P.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 1, 2002-01 ,pp. : 31-33

Elsevier

Access to resources Recommend Favorite

Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. - J. Urol 2002;167:80-83.

By Boman H.   Hedelin H.   Holmang S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 163-164

Elsevier

Access to resources Recommend Favorite

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. - J urol 2002;167:1295-1298.

By Herr H.W.   Bochner B.H.   Dalbagni G.   Donat S.M.   Reuter V.E.   Bajorin D.F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 168-169

Elsevier

Access to resources Recommend Favorite

Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumours

By Watters A.D.   Going J.J.   Grigor K.M.   Bartlett J.M.S.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1593-1599

Elsevier

Access to resources Recommend Favorite